All In Biotech

Drug Trial Radar · NCT00106691

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)

Last checked: Nov 20, 2026Latest source record: Jun 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,589 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,589

Actual

Start

Jan 2005

Primary completion

Feb 2010

Study completion Feb 2010

Sponsor

Lead sponsor
GTxIndustry
Sponsor type
Industry
First posted
Mar 30, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Prevention
Who can join
Male only, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if toremifene citrate is effective and safe in the prevention of prostate cancer in men who have been diagnosed with high grade prostatic intraepithelial neoplasia (PIN).

Conditions

  • Preneoplastic Conditions
  • Prostatic Intraepithelial Neoplasia

Interventions

  • Toremifene 20 mgDrug

    The subject takes one dose by mouth of the 20mg Toremifine Citrate tablet once a day for the length of the trial (360 days).

  • PlaceboDrug

    The subject takes a placebo tablet identical in appearance to the toremifene 20mg tablet, administered by mouth daily for 360 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of Toremifene in the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)Time frame: The outcome measurement time is up to 36 months
  2. Occurrence of a Positive Cancer BiopsyTime frame: Up to 36 months

Locations

138 sites in 3 countries. Site status is shown where the registry gives one.

  • Medical Affiliated Research Ctr.

    Huntsville, Alabama

  • Coastal Clinical Research

    Mobile, Alabama

  • Hope Research Inst.

    Phoenix, Arizona

  • Arkansas Urology

    Little Rock, Arkansas

  • San Bernardino Urological Associates Medical Group

    San Bernardino, California

  • Western Clinical Research, Inc.

    Torrance, California

  • Urology Research Options

    Aurora, Colorado

  • Urology Associates, P.C.

    Denver, Colorado

  • The Urology Center of Colorado

    Denver, Colorado

  • Connecticut Surgical Group

    Hartford, Connecticut

  • Urological Associates of Bridgeport

    Trumbull, Connecticut

  • Connecticut Clinical Research

    Waterbury, Connecticut

  • South Florida Medical Research

    Aventura, Florida

  • Atlantic Urological Associates

    Daytona Beach, Florida

  • Southwest Florida Urologic Associates

    Fort Myers, Florida

  • Advanced Research Institute

    New Port Richey, Florida

  • UroSearch

    Ocala, Florida

  • Central Florida Urology Group/ UroSearch

    Ocala, Florida

  • Florida Foundation for Healthcare Research

    Ocala, Florida

  • Winter Park Urology Associates

    Orlando, Florida

  • Panama City Urological Center

    Panama City, Florida

  • Demaur Clinical Research Center

    Pembroke Pines, Florida

  • DMI Research

    Pinellas Park, Florida

  • Urology Consultants

    Pinellas Park, Florida

  • Florida Urology Specialists

    Sarasota, Florida

  • Midtown Urology

    Atlanta, Georgia

  • Georgia Urology

    Atlanta, Georgia

  • Urology Enterprises

    Marietta, Georgia

  • North Fulton Urology

    Roswell, Georgia

  • St. Joseph's, Candler Health System

    Savannah, Georgia

  • Specialty Care Research

    Peoria, Illinois

  • Urology of Indiana, LLC

    Indianapolis, Indiana

  • Metropolitan Urology, PSC

    Jeffersonville, Indiana

  • Kansas City Urology Care, P.C.

    Overland Park, Kansas

  • Regional Urology, LLC

    Shreveport, Louisiana

  • Anne Arundel Urology

    Annapolis, Maryland

  • Maryland Prostate Center: University of Maryland Medical Center

    Baltimore, Maryland

  • Drs. Werner, Murdock, & Francis PA, Urology Associates

    Greenbelt, Maryland

  • Urology Center, PA

    Hagerstown, Maryland

  • Mid Atlantic Clinical Research

    Rockville, Maryland

Showing 40 of 138 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.